Andere Sprachen Nanoform Finland Oyj

Aktien

A2P5N7

FI4000330972

NANOFH

Markt geschlossen - Nasdaq Helsinki Andere Börsenplätze 17:24:51 23.05.2024			% 5 Tage	% 1. Jan.
2 ^EUR	+3,52 %		-0,25 %	+26,18 %

11.04.	Nanoform Finland liefert Nanomedizin-Technologie nach Japan	MT
11.04.	Nanoform geht exklusive Partnerschaft mit CBC ein, um erstklassige Nanomedizin-Technologie nach Japan zu bringen	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Invitation to Nanoform's Q1 2024 Report Presentation	16.05.
Nanoformed High-Concentration Biologics Formulation for Subcutaneous Delivery Results to be Presented by Takeda at DDF Summit	07.05.
Disclosure of Major Holdings under Law 163/2024	26.04.
New shares of Nanoform registered with the trade register	25.04.
Nanoform successfully completes new share issue raising EUR 15.4 million to invest in commercialization of nanoparticle enabled formulations for next generation medicines	24.04.
Nanoform announces its intention to carry out a new share issue of approximately 7 million new shares to invest in commercialization of nanoparticle enabled formulations for next generation medicines	24.04.
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc	16.04.
Resolutions of Nanoform Finland Plc's Annual General Meeting on April 16, 2024	16.04.
Nanoform Finland to Deliver Nanomedicine Technology to Japan	11.04.
Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan	11.04.
Nanoform Enters Exclusive Partnership with CBC to Bring Best-In-Class Nanomedicine Technology to Japan	11.04.
Nanoform Teams Up with PlusVitech to Repurpose Anti-Nausea Drug for Lung Cancer Treatment	09.04.
Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer	09.04.
Nanoform Finland plc and Plusvitech Partner to Repurpose Aprepitant as A Treatment for Lung Cancer	09.04.
Nanoform Finland Plc: Certified Adviser change to Carnegie Investment Bank Ab	08.04.
The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key individuals	26.03.
Notice to the Annual General Meeting of NANOFORM FINLAND Plc	12.03.
Share subscriptions based on Nanoform Finland Plc's stock options 2/2019 and 1/2020	12.03.
Nanoform Finland Plc - Manager's transactions - Miguel Calado	06.03.
Nanoform Finland Plc - Manager's transactions - Mads Laustsen	06.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Nanoform Finland Oyj

Aktien

A2P5N7

FI4000330972

NANOFH

Andere Sprachen

Filter